You are here: IDTechEx.com » タイムライン » Galvani Bioelectronics

Galvani Bioelectronics

» タイムライン » Galvani Bioelectronics

Galvani Bioelectronics

Profile
Formed through a partnership between global healthcare company, GSK, and leading technology company, Verily Life Sciences, Galvani Bioelectronics combines the complementary expertise of its parent companies to enable the research, development and commercialisation of bioelectronic therapies.
 
Bioelectronic medicine is an emerging scientific field, aiming to use tiny implantable devices to change precise electrical signals in nerves to treat a range of debilitating chronic diseases. Galvani Bioelectronics represents an important step change in the research and development of these medicines, combining GSK's discovery and development expertise and deep understanding of disease biology with Verily's world leading expertise in the miniaturisation of low power electronics, device development, data analytics and software development for clinical applications.
フィルター:
Galvani Bioelectronics
Company
Topic
Show
 
2019
5 Mar

Nexeon MedSystems

Nexeon MedSystems is a bioelectronic medicine company developing medical devices for the treatment of movement disorders.
2018
9 Nov

Bioelectronic Medicine 2019-2029

IDTechEx Report: Dr Nadia Tsao
11 Apr

Bioelectronic Medicine

Galvani Bioelectronics, United Kingdom
21 Mar

Five Hot Trends with Printed and Flexible Electronics

Europe's leading event on printed and flexible electronics, Printed Electronics Europe 2018, opens its doors in less than three weeks to over 2,500 global visitors.
1 Mar

Wearable technology: Growth opportunities after the hype

The IDTechEx Wearable Europe conference and exhibition, to be held on 11-12 April in Berlin Germany, brings together the ecosystem global brands with leading edge technology developers, focussing on the commercial growth opportunities for wearable technology.
23 Jan

Electronic modulation of carotid sinus nerve

Researchers demonstrated through findings in rats that it is possible to restore insulin sensitivity and glucose homeostasis, by modulating electrically the carotid sinus nerve, the sensitive nerve that connects the carotid body with the brain.
2017
15 Nov

Bioelectronic Medicine

Galvani Bioelectronics, United Kingdom
7 Nov

Record Bookings For The IDTechEx Show!

Over 3,000 attendees, 250 exhibitors and 240 speakers will converge at the Santa Clara Convention Center on November 15-16 for the IDTechEx Show!
26 Oct

NASCAR, JCDecaux, Galvani and Terrafugia to open the IDTechEx Show!

Opening the IDTechEx Show! in Santa Clara, Nov 15-16, are four select Cornerstone presentations which will showcase how new technologies are coming to market which solve big problems created by changing demographics and global megatrends, from mobility to healthcare to enabling the ubiquity of electronics.
26 Sep

Sensors are the stars of the IDTechEx Show!

Sensors conference features the latest technologies for Healthcare, Wearables, IoT, and Mobile devices.
8 Sep

Implantable devices to alter electrical impulses in the body

GSK has announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines.
15 May

The shock tactics set to shake up immunology

Vagus-nerve stimulation, has been used since the 1990s to treat epilepsy, and since the early 2000s to treat depression
10 May

Road Mapping Bioelectronic Medicine

Galvani Bioelectronics, United Kingdom
3 May

IDTechEx Show! Exhibition Grows by 30%

On May 10-11 an estimated 3,000 people from over 40 countries will meet at the Estrel Convention Centre in Berlin to discuss the commercialization of a diverse range of emerging technologies.
26 Apr

Toyota, ARM, VF Global, Galvani Bioelectronics to Open IDTechEx Show!

The IDTechEx Show! in Berlin, Germany on 10-11 May is Europe's most important event for those involved in technology scouting and product innovation, bringing together emerging technologies with global brands.
30 Mar

The global attitude to the wearable technology industry is changing

As the hype fades, companies are increasingly focused on specific and varied product opportunities within this diverse space.
6 Feb

How Big Pharma is betting on electronics

As the business model for commercializing new drugs becomes increasingly more difficult to sustain, the pharmaceutical industry is trying to reinvent itself. One bet is on electronic devices that could provide direct treatment of some chronic diseases. The race is on to find new materials that will be compatible for this new form of medicine.